182 related articles for article (PubMed ID: 24680597)
1. Obesity increases tumor aggressiveness in a genetically engineered mouse model of serous ovarian cancer.
Makowski L; Zhou C; Zhong Y; Kuan PF; Fan C; Sampey BP; Difurio M; Bae-Jump VL
Gynecol Oncol; 2014 Apr; 133(1):90-7. PubMed ID: 24680597
[TBL] [Abstract][Full Text] [Related]
2. The effect of celecoxib on tumor growth in ovarian cancer cells and a genetically engineered mouse model of serous ovarian cancer.
Suri A; Sheng X; Schuler KM; Zhong Y; Han X; Jones HM; Gehrig PA; Zhou C; Bae-Jump VL
Oncotarget; 2016 Jun; 7(26):39582-39594. PubMed ID: 27074576
[TBL] [Abstract][Full Text] [Related]
3. High-fat diet and obesity are associated with differential angiogenic gene expression in epithelial ovarian cancer.
Baumann KE; Siamakpour-Reihani S; Dottino J; Dai Y; Bentley R; Jiang C; Zhang D; Sibley AB; Zhou C; Berchuck A; Owzar K; Bae-Jump V; Secord AA
Gynecol Oncol; 2023 Dec; 179():97-105. PubMed ID: 37956617
[TBL] [Abstract][Full Text] [Related]
4. Obesity and altered angiogenic-related gene expression in endometrial cancer.
Cobb LP; Siamakpour-Reihani S; Zhang D; Qin X; Owzar K; Zhou C; Conrads TP; Maxwell GL; Darcy KM; Bateman NW; Litzi T; Bae-Jump V; Secord AA
Gynecol Oncol; 2021 Nov; 163(2):320-326. PubMed ID: 34538531
[TBL] [Abstract][Full Text] [Related]
5. Perturbation of Rb, p53, and Brca1 or Brca2 cooperate in inducing metastatic serous epithelial ovarian cancer.
Szabova L; Yin C; Bupp S; Guerin TM; Schlomer JJ; Householder DB; Baran ML; Yi M; Song Y; Sun W; McDunn JE; Martin PL; Van Dyke T; Difilippantonio S
Cancer Res; 2012 Aug; 72(16):4141-53. PubMed ID: 22617326
[TBL] [Abstract][Full Text] [Related]
6. Everolimus exhibits anti-tumorigenic activity in obesity-induced ovarian cancer.
Guo H; Zhong Y; Jackson AL; Clark LH; Kilgore J; Zhang L; Han J; Sheng X; Gilliam TP; Gehrig PA; Zhou C; Bae-Jump VL
Oncotarget; 2016 Apr; 7(15):20338-56. PubMed ID: 26959121
[TBL] [Abstract][Full Text] [Related]
7. A genetically engineered ovarian cancer mouse model based on fallopian tube transformation mimics human high-grade serous carcinoma development.
Sherman-Baust CA; Kuhn E; Valle BL; Shih IeM; Kurman RJ; Wang TL; Amano T; Ko MS; Miyoshi I; Araki Y; Lehrmann E; Zhang Y; Becker KG; Morin PJ
J Pathol; 2014 Jul; 233(3):228-37. PubMed ID: 24652535
[TBL] [Abstract][Full Text] [Related]
8. Increased efficacy of metformin corresponds to differential metabolic effects in the ovarian tumors from obese
Han J; Wysham WZ; Zhong Y; Guo H; Zhang L; Malloy KM; Dickens HK; Huh G; Lee D; Makowski L; Zhou C; Bae-Jump VL
Oncotarget; 2017 Dec; 8(67):110965-110982. PubMed ID: 29340030
[TBL] [Abstract][Full Text] [Related]
9. Pathway-specific engineered mouse allograft models functionally recapitulate human serous epithelial ovarian cancer.
Szabova L; Bupp S; Kamal M; Householder DB; Hernandez L; Schlomer JJ; Baran ML; Yi M; Stephens RM; Annunziata CM; Martin PL; Van Dyke TA; Weaver Ohler Z; Difilippantonio S
PLoS One; 2014; 9(4):e95649. PubMed ID: 24748377
[TBL] [Abstract][Full Text] [Related]
10. Impact of obesity on chemotherapy dosing for women with advanced stage serous ovarian cancer in the Australian Ovarian Cancer Study (AOCS).
Au-Yeung G; Webb PM; DeFazio A; Fereday S; Bressel M; Mileshkin L
Gynecol Oncol; 2014 Apr; 133(1):16-22. PubMed ID: 24680586
[TBL] [Abstract][Full Text] [Related]
11. Untargeted and targeted gingival metabolome in rodents reveal metabolic links between high-fat diet-induced obesity and periodontitis.
Chen ZY; Xu TT; Liang ZJ; Zhao L; Xiong XQ; Xie KK; Yu WX; Zeng XW; Gao J; Zhou YH; Luo G; Yu T
J Clin Periodontol; 2021 Aug; 48(8):1137-1148. PubMed ID: 33998036
[TBL] [Abstract][Full Text] [Related]
12. Weight-reduction through a low-fat diet causes differential expression of circulating microRNAs in obese C57BL/6 mice.
Hsieh CH; Rau CS; Wu SC; Yang JC; Wu YC; Lu TH; Tzeng SL; Wu CJ; Lin CW
BMC Genomics; 2015 Sep; 16(1):699. PubMed ID: 26377847
[TBL] [Abstract][Full Text] [Related]
13. Reversal of obesity-driven aggressiveness of endometrial cancer by metformin.
Guo H; Kong W; Zhang L; Han J; Clark LH; Yin Y; Fang Z; Sun W; Wang J; Gilliam TP; Lee D; Makowski L; Zhou C; Bae-Jump VL
Am J Cancer Res; 2019; 9(10):2170-2193. PubMed ID: 31720081
[TBL] [Abstract][Full Text] [Related]
14. Obesity modulates the cellular and molecular microenvironment in the peritoneal cavity: implication for ovarian cancer risk.
Shea AA; Heffron CL; Grieco JP; Roberts PC; Schmelz EM
Front Immunol; 2023; 14():1323399. PubMed ID: 38264656
[TBL] [Abstract][Full Text] [Related]
15. Genetic determinants of FOXM1 overexpression in epithelial ovarian cancer and functional contribution to cell cycle progression.
Barger CJ; Zhang W; Hillman J; Stablewski AB; Higgins MJ; Vanderhyden BC; Odunsi K; Karpf AR
Oncotarget; 2015 Sep; 6(29):27613-27. PubMed ID: 26243836
[TBL] [Abstract][Full Text] [Related]
16. Effect of Low-Fat Diet in Obese Mice Lacking Toll-like Receptors.
Rau CS; Wu SC; Lu TH; Wu YC; Wu CJ; Chien PC; Kuo PJ; Lin CW; Tsai CW; Hsieh CH
Nutrients; 2018 Oct; 10(10):. PubMed ID: 30304787
[No Abstract] [Full Text] [Related]
17. Host obesity alters the ovarian tumor immune microenvironment and impacts response to standard of care chemotherapy.
Liu Y; Yang J; Hilliard TS; Wang Z; Johnson J; Wang W; Harper EI; Ott C; O'Brien C; Campbell L; Crowley B; Grisoli S; Stavrou NM; Juncker-Jensen A; Stack MS
J Exp Clin Cancer Res; 2023 Jul; 42(1):165. PubMed ID: 37438818
[TBL] [Abstract][Full Text] [Related]
18. Diet-induced obesity increases tumor growth and promotes anaplastic change in thyroid cancer in a mouse model.
Kim WG; Park JW; Willingham MC; Cheng SY
Endocrinology; 2013 Aug; 154(8):2936-47. PubMed ID: 23748362
[TBL] [Abstract][Full Text] [Related]
19. Targeting dopamine receptor D2 as a novel therapeutic strategy in endometrial cancer.
Pierce SR; Fang Z; Yin Y; West L; Asher M; Hao T; Zhang X; Tucker K; Staley A; Fan Y; Sun W; Moore DT; Xu C; Tsai YH; Parker J; Prabhu VV; Allen JE; Lee D; Zhou C; Bae-Jump V
J Exp Clin Cancer Res; 2021 Feb; 40(1):61. PubMed ID: 33557912
[TBL] [Abstract][Full Text] [Related]
20. Inactivation of TRP53, PTEN, RB1, and/or CDH1 in the ovarian surface epithelium induces ovarian cancer transformation and metastasis.
Shi M; Whorton AE; Sekulovski N; Paquet M; MacLean JA; Song Y; Van Dyke T; Hayashi K
Biol Reprod; 2020 Apr; 102(5):1055-1064. PubMed ID: 31930396
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
